FibreTuff News: On April 23, 2018 FibreTuff President and Founder Robert Joyce received notification from NAMSA that testing of FibreTuff PAPC passed USP Class VI for temporary implants. The FibreTuff PAPC filament that complied with testing can be 3D Printed.
FOR IMMEDIATE RELEASE: 3/6/2018
FibreTuff Medical Biopolymers, LLC
Toledo, OH: Today, FibreTuff Medical Biopolymers, LLC a biomaterials compounder has entered into an exclusive agreement with Keene Village Plastics to supply FibreTuff PAPC ( Polyamide, Polyolefin and Cellulose ) licensed compounds for 3D Printing in the medical market. In the agreement, Keene Village Plastics responsibilities will include manufacturing and distributing FibreTuff PAPC in 1.75 and 3.0mm size filaments and distribute various PAPC Bar and Sheet Stock.
CIFT is pleased to welcome you to the collaboration announcement between FibreTuff Medical Biopolymers, LLC, Whiteside Orthotic and Prosthetic Group, Inc., JuggerBot3D, LLC,Valtronic, Mercy Health and Ohio Development Services Agency to advance the design and
production of medical devices using innovative, FDA-compliant ingredients and additive manufacturing (also known as 3-D printing) technologies on Tuesday, March 13, 2018.
This announcement at Mercy Health will also feature a demonstration of 3-D printing as well as a showcase of 3-D printed materials.
The statewide project will be executed in three phases by:
1. Qualifying three different biomaterial formulas for the 3-D printing process.
2. Designing and 3-D printing medical devices using three biomaterials, and,
3. Developing conceptual prototypes for "smart" devices using 3-D printed designs
FibreTuff LLC Team Members - 60+ years of compounding / biomaterials experience
Robert Joyce, President the founder of the company, the inventor of the company’s technology and has over 30 years in bio compounding business and development, production and manufacturing.
Ted Walkowski, Chief Operating Officer, has over 20-years of compounding and production management experience, and was the co-founder of Trinity Specialty Compounding.
Robert Joyce President and Founder will discuss FibreTuff advanced material technology to produce a cervical spacer made with FibreTuff PAPC having 6000 psi compression strength.
PAPC is now a registered USPTO trademark. S/N 87565236 assigned to FibreTuff Medical Biopolymers
FibreTuff Develops Filaments for 3D Printing by Plastics News January 5, 2018 http://www.plasticsnews.com/article/20180105/NEWS/180109943/fibretuff-develops-filaments-for-3d-printing
FibreTuff Medical Biopolymers, LLC has a new Chief Operating Officer and partner Ted Walkowski. Ted has over 20 years of plastic compounding experience with responsibilities of plant operational and management experience. Welcome Ted !!!
FibreTuff is looking for dedicated service providers to 3D Print our PAPC compounds. Contact Robert at email listed below
If you have a medical background with advanced materials experience and education send us a resume. We will have job postings in the future.
Brian Jones joins FibreTuff Medical Biopolymers as a partner to be Director of Regulatory and Quality for the company. Brian has over 15 years experience in compounding thermoplastic.
FibreTuff has opened a compounding facility to produce PAPC biomaterial compounds for the medical industry.
3D Printing news includes the printing of medical implants with FibreTuff PAPC filaments which have radiopacity shown in X rays and CT Scans versus other polymers that require much heavier barium sulfate...
Robert Joyce of FibreTuff attended the event held in San Francisco to discuss FibreTuff for development and use in Spinal applications to reduce costs in replacement of PEEK.
In March 25, 2015 FibreTuff Medical Biopolymers has signed an exclusive license for the know how and licensing of FibreTuff technology for compounds that comprise cellulose with thermoplastic polymers.
FibreTuff at Mercy Health Event March 13, 2018